Clinical Trial

A Hypnosis-based Group Intervention to Improve Quality of Life in Children With Cancer and Their Parents.

Recruiting
View on ClinicalTrials.gov →
Summary
Background: A lot of children with cancer suffer from emotional distress, fatigue and relational difficulties. Their parents are also impacted by the disease: their responsibilities increase and they can feel more distressed and tired. Different psychological interventions designed for ill children and their parents seem to be efficient to improve their social functioning, coping strategies and well-being. However, more research is needed in this field. Hypnosis is often used in paediatric oncology, mostly to decrease procedure-related pain and distress. It has been used efficiently to improve the well-being of adults with cancer. This paper describes a pilot study designed to assess the feasibility and interest of a group intervention combining self-care and hypnosis for children with cancer and their parents, and a quasi-experimental protocol aimed at assessing the efficacy of this group intervention to improve the quality of life of children and their parents. Methods: Our pilot study showed that our intervention was feasible and positive for the participants. To test the efficacy of the intervention, two groups will be set up: one with children with cancer and their interested siblings, and one with their parents. Data will be collected for each group before and after the intervention by questionnaires and a semi-structured interview. Discussion: There is a growing interest in hypnosis in oncology settings. The results of this study should improve knowledge about the efficacy of a group intervention combining self-care and hypnosis to improve quality of life of children with cancer and their family.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2018-02-14; most recent amendment 2023-06-29.
Status change: Suspended → Recruiting 2023-06-29
Status change: Recruiting → Suspended 2020-09-24
Trial Details
NCT Number NCT03435042
Lead Sponsor University of Liege
Conditions Pediatric Cancer
Enrollment 30 participants
Start Date 2018-01-25
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-07-03